Factory Mutual Insurance Co. Grows Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Factory Mutual Insurance Co. lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 4.3% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 234,500 shares of the healthcare conglomerate’s stock after purchasing an additional 9,600 shares during the period. UnitedHealth Group comprises approximately 1.3% of Factory Mutual Insurance Co.’s portfolio, making the stock its 13th biggest holding. Factory Mutual Insurance Co.’s holdings in UnitedHealth Group were worth $116,007,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Bell Investment Advisors Inc grew its position in shares of UnitedHealth Group by 4.8% in the 4th quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock worth $276,000 after buying an additional 24 shares during the period. Harbor Investment Advisory LLC boosted its position in shares of UnitedHealth Group by 3.2% in the 1st quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock worth $17,783,000 after purchasing an additional 1,129 shares in the last quarter. Verdence Capital Advisors LLC increased its position in UnitedHealth Group by 2.1% during the 4th quarter. Verdence Capital Advisors LLC now owns 16,941 shares of the healthcare conglomerate’s stock valued at $8,919,000 after buying an additional 342 shares in the last quarter. Austin Private Wealth LLC boosted its holdings in UnitedHealth Group by 9.8% in the first quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock worth $573,000 after acquiring an additional 111 shares in the last quarter. Finally, Bellecapital International Ltd. raised its position in shares of UnitedHealth Group by 1.4% in the 4th quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock worth $7,277,000 after purchasing an additional 193 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 1.1 %

UNH stock opened at $484.60 on Wednesday. The business’s 50-day moving average is $498.20 and its 200 day moving average is $502.75. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The stock has a market cap of $446.02 billion, a price-to-earnings ratio of 29.62, a PEG ratio of 1.42 and a beta of 0.58. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. UnitedHealth Group’s revenue was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $6.26 EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.57 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.73%. The ex-dividend date was Monday, June 17th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s payout ratio is currently 51.34%.

Wall Street Analyst Weigh In

UNH has been the subject of several analyst reports. JPMorgan Chase & Co. raised their price target on shares of UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research report on Thursday, May 30th. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, June 20th. Piper Sandler upped their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a report on Friday, April 19th. Finally, Baird R W raised shares of UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. Three investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $579.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.